SAB Biotherapeutics
Earnings Surprise
Analysts estimated SABS earnings of $-0.20 per share this quarter (Q4). SABS's actual earnings were $-0.35 per share.
SABS EPS surprise of -72.67%Analysts estimated SABS earnings of $-0.52 per share this quarter (Q3). SABS's actual earnings were $-0.15 per share.
SABS EPS surprise of 70.94%Analysts estimated SABS earnings of $-0.81 per share this quarter (Q2). SABS's actual earnings were $-1.09 per share.
SABS EPS surprise of -34.25%Analysts estimated SABS earnings of $-1.05 per share this quarter (Q1). SABS's actual earnings were $-0.56 per share.
SABS EPS surprise of 46.70%Analysts estimated SABS earnings of $-1.15 per share this quarter (Q2). SABS's actual earnings were $-0.79 per share.
SABS EPS surprise of 31.46%Analysts estimated SABS earnings of $-0.98 per share this quarter (Q1). SABS's actual earnings were $-0.60 per share.
SABS EPS surprise of 38.73%Analysts estimated SABS earnings of $-0.63 per share this quarter (Q4). SABS's actual earnings were $-3.38 per share.
SABS EPS surprise of 434.47%Analysts estimated SABS earnings of $-1.19 per share this quarter (Q3). SABS's actual earnings were $-1.00 per share.
SABS EPS surprise of -15.97%